This happened about a month ago but I only now got around to reading ars' take on it, Gene patents may not survive breast cancer test ruling.
"Yesterday, a judge in New York issued a sweeping decision that, if upheld following a seemingly inevitable appeal, may put most gene patents on shaky ground. The ACLU, various researchers, and medical advocacy groups had sued Myriad genetics and the University of Utah, which held patents that covered tests for mutations in the BRCA genes, which predispose their carriers to breast and ovarian cancers (the US Patent and Trademark Office was also sued, for good measure). Just about everyone involved requested summary judgement, and the ruling grants it in favor of the plaintiffs, invalidating Myriad's patents in the process."
Sounds like a good decision.
No comments:
Post a Comment